Sri Sri Tattva bring you an addition to our team of Immunity Building Range- Ayush64. This formulation is developed in compliance to all regulatory requirements and quality and pharmacopoeial standards by the Central Council for Research in Ayurvedic Science.
Ayurvedic polyherbal formulation AYUSH 64 has been found useful in the treatment of asymptomatic, mild and moderate COVID-19 infection. AYUSH 64 was developed by CCRAS for treating Malaria in 1980, the drug has now been repurposed to treat COVID -19, and has been found effective in a study carried out by AYUSH ministry in collaboration with CSIR. The Ministry of AYUSH, Govt. of India has recommended this medicine in the national clinical management protocol based on Ayurveda and Yoga.
